Motonobu Osada

3.5k total citations
46 papers, 2.8k citations indexed

About

Motonobu Osada is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Motonobu Osada has authored 46 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 23 papers in Oncology and 8 papers in Surgery. Recurrent topics in Motonobu Osada's work include Cancer-related Molecular Pathways (16 papers), Epigenetics and DNA Methylation (13 papers) and RNA modifications and cancer (12 papers). Motonobu Osada is often cited by papers focused on Cancer-related Molecular Pathways (16 papers), Epigenetics and DNA Methylation (13 papers) and RNA modifications and cancer (12 papers). Motonobu Osada collaborates with scholars based in Japan, United States and Germany. Motonobu Osada's co-authors include David Sidransky, Keishi Yamashita, Masaki Mori, Hannah Lui Park, Myoung Sook Kim, Barry Trink, Shuntaro Ikawa, Sunil Upadhyay, Ryunosuke Kanamaru and Yoji Ikawa and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Molecular and Cellular Biology.

In The Last Decade

Motonobu Osada

46 papers receiving 2.8k citations

Peers

Countries citing papers authored by Motonobu Osada

Since Specialization

Citations

This map shows the geographic impact of Motonobu Osada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Motonobu Osada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Motonobu Osada more than expected).

Fields of papers citing papers by Motonobu Osada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Motonobu Osada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Motonobu Osada. The network helps show where Motonobu Osada may publish in the future.

Co-authorship network of co-authors of Motonobu Osada

This figure shows the co-authorship network connecting the top 25 collaborators of Motonobu Osada. A scholar is included among the top collaborators of Motonobu Osada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Motonobu Osada. Motonobu Osada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Patients with Esophageal Squamous Cell Carcinoma: Results from a Phase 1 Cohort in Asia 2021 ·Targeted Oncology ·Chia‐Chi Lin, Toshihiko Doi, Kei Muro, Ming-Mo Hou, Taito Esaki, Hiroki Hara, Hyun Cheol Chung, Christoph Helwig, Isabelle Dussault, Motonobu Osada, Shunsuke Kondo	22
2	P5-5 Phase 2/3 study of bintrafusp alfa with gemcitabine plus cisplatin as first-line treatment of biliary tract cancer 2021 ·Annals of Oncology ·Do‐Youn Oh, Filippo de Braud, John Bridgewater, Junji Furuse, Chih‐Hung Hsu, Masafumi Ikeda, Sunyoung Lee, Markus Moehler, Joon Oh Park, Lin Shen, Changhoon Yoo, Christoph Helwig, Motonobu Osada, Mitesh J. Borad	4
3	Safety and Tolerability of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Asian Patients with Pretreated Recurrent or Refractory Gastric Cancer 2020 ·Clinical Cancer Research ·Yoon‐Koo Kang, Yung‐Jue Bang, Shunsuke Kondo, Hyun Cheol Chung, Kei Muro, Isabelle Dussault, Christoph Helwig, Motonobu Osada, Toshihiko Doi	31
4	A Phase I study of intravenous PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumors 2016 ·Cancer Chemotherapy and Pharmacology ·Toshihiko Doi, Nozomu Fuse, Takayuki Yoshino, Takashi Kojima, Hideaki Bando, Hideaki Miyamoto, (unknown), Motonobu Osada, Atsushi Ohtsu	33
5	HOP/OB1/NECC1 Promoter DNA Is Frequently Hypermethylated and Involved in Tumorigenic Ability in Esophageal Squamous Cell Carcinoma 2008 ·Molecular Cancer Research ·Keishi Yamashita, Myoung Sook Kim, Hannah Lui Park, Yutaka Tokumaru, Motonobu Osada, Hiroshi Inoue, Masaki Mori, David Sidransky	47
6	DCC promoter hypermethylation in esophageal squamous cell carcinoma 2008 ·International Journal of Cancer ·Hannah Lui Park, Myoung Sook Kim, Keishi Yamashita, William H. Westra, André Lopes Carvalho, Juna Lee, Wei‐Wen Jiang, Jin Hyen Baek, Junwei Liu, Motonobu Osada, Chulso Moon, Joseph A. Califano, Masaki Mori, David Sidransky	40
7	A Promoter Methylation Pattern in the N -Methyl- d -Aspartate Receptor 2B Gene Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma 2007 ·Clinical Cancer Research ·Myoung Sook Kim, Keishi Yamashita, Young Kwang Chae, Yutaka Tokumaru, Xiaofei Chang, Marianna Zahurak, Motonobu Osada, Hannah Lui Park, Alice Chuang, Joseph A. Califano, David Sidransky	20
8	A p53-type response element in the GDF15 promoter confers high specificity for p53 activation 2007 ·Biochemical and Biophysical Research Communications ·Motonobu Osada, Hannah Lui Park, (unknown), Jun-Wei Liu, Guojun Wu, Barry Trink, David Sidransky	68
9	N- Methyl- d -Aspartate Receptor Type 2B Is Epigenetically Inactivated and Exhibits Tumor-Suppressive Activity in Human Esophageal Cancer 2006 ·Cancer Research ·Myoung Sook Kim, Keishi Yamashita, Jin Hyen Baek, Hannah Lui Park, André Lopes Carvalho, Motonobu Osada, Mohammad Obaidul Hoque, Sunil Upadhyay, Masaki Mori, Chulso Moon, David Sidransky	93
10	Overexpression of Glycosylphosphatidylinositol (GPI) Transamidase Subunits Phosphatidylinositol Glycan Class T and/or GPI Anchor Attachment 1 Induces Tumorigenesis and Contributes to Invasion in Human Breast Cancer 2006 ·Cancer Research ·Guojun Wu, Zhongmin Guo, Aditi Chatterjee, Xin Huang, Ethel Rubin, Feng Wu, Elizabeth Mambo, Xiaofei Chang, Motonobu Osada, Myoung Sook Kim, Chulso Moon, Joseph A. Califano, Edward A. Ratovitski, Susanne M. Gollin, Saraswati Sukumar, David Sidransky, Barry Trink	51
11	PGP9.5 Methylation in Diffuse-Type Gastric Cancer 2006 ·Cancer Research ·Keishi Yamashita, Hannah Lui Park, Myoung Sook Kim, Motonobu Osada, Yutaka Tokumaru, Hiroshi Inoue, Masaki Mori, David Sidransky	68
12	DCC promoter hypermethylation in esophageal squamous cell carcinoma 2006 ·Cancer Research ·Hannah Lui Park, Keishi Yamashita, Myoung Sook Kim, William H. Westra, André Lopes Carvalho, Jin Hyen Baek, (unknown), Junwei Liu, Motonobu Osada, Joseph A. Califano, Masaki Mori, David Sidransky	8
13	NMDA receptor type 2A at 16p13 is epigenetically inactivated in human colorectal carcinoma 2006 ·Cancer Research ·Myoung Sook Kim, Junwei Liu, Keishi Yamashita, Xiaofei Chang, Jin Hyen Baek, (unknown), (unknown), Motonobu Osada, Sunil Upadhyay, Chulso Moon, David Sidransky	2
14	ΔNp63α Up-Regulates the Hsp70 Gene in Human Cancer 2005 ·Cancer Research ·Guojun Wu, Motonobu Osada, Zhongmin Guo, Alexey Fomenkov, Shahnaz Begum, Ming Zhao, Sunil Upadhyay, Mingzhao Xing, Feng Wu, Chulso Moon, William H. Westra, Wayne M. Koch, Roberto Mantovani, Joseph A. Califano, Edward A. Ratovitski, David Sidransky, Barry Trink	88
15	p63-Specific Activation of the BPAG-1e Promoter 2005 ·Journal of Investigative Dermatology ·Motonobu Osada, Yuichi Nagakawa, Hannah Lui Park, Keishi Yamashita, Guojun Wu, Myoung Sook Kim, Alexey Fomenkov, Barry Trink, David Sidransky	35
16	p51/p63 Controls Subunit α3 of the Major Epidermis Integrin Anchoring the Stem Cells to the Niche 2004 ·Journal of Biological Chemistry ·Shun‐ichi Kurata, (unknown), Motonobu Osada, Tatsuya Watanabe, Yoshiya Tomimori, Shingo Sato, Aki Iwai, Tsutomu Tsuji, Yoji Ikawa, Iyoko Katoh	55
17	Altered Sumoylation of p63α Contributes to the Split-Hand/Foot Malformation Phenotype 2004 ·Cell Cycle ·Yi‐Ping Huang, Guojun Wu, Zhongmin Guo, Motonobu Osada, (unknown), Hannah Lui Park, Barry Trink, David Sidransky, Alexey Fomenkov, Edward A. Ratovitski	47
18	Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma 2002 ·Cancer Cell ·Keishi Yamashita, Sunil Upadhyay, Motonobu Osada, Mohammad Obaidul Hoque, Xiao Yan, Masaki Mori, Fumiaki Sato, Stephen J. Meltzer, David Sidransky	283
19	p53 Gene Family p51(p63)-Encoded, Secondary Transactivator p51B(TAp63α) Occurs without Forming an Immunoprecipitable Complex with MDM2, but Responds to Genotoxic Stress by Accumulation 2002 ·Experimental Cell Research ·Yohei Okada, Motonobu Osada, Shun‐ichi Kurata, Shingo Sato, Ken‐ichi Aisaki, Yukio Kageyama, Kazunori Kihara, Yoji Ikawa, Iyoko Katoh	39
20	Regulatory Domain of Protein Stability of Human P51/TAP63, a P53 Homologue 2001 ·Biochemical and Biophysical Research Communications ·Motonobu Osada, (unknown), Hisaaki Shinohara, Masatoshi Hagiwara, Masataka Nakamura, Yoji Ikawa	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact